Detection of Lymphoid and Myeloid Lineages in Infantile B-Cell Acute Lymphoblastic Leukemia With Mixed-Lineage Leukemia Rearrangement by Use of Flow Cytometry and Cytogenetic Analysis

Using CD19 chimeric antigen receptor‐T cell therapy in a 4‐month‐old patient with infantile acute lymphoblastic leukemia

“…To the Editor: Long‐term survival in infantile acute lymphoblastic leukemia (iALL) remains below 50% . CD19 chimeric antigen receptor T (CAR‐T) cell therapy is a promising treatment for relapsed/refractory B‐lineage ALL; however, experience is limited in iALL .…”